Showing results (131-140 of 213) with videos related to
Sort By:
Pageof 22
RSC Advances|January 22, 2026
Harnessing Frémy's salt for tyrosine-directed bioconjugationsZachary V Samuels, Ava Stoddard, Wei-Siang Mark Kao, et al.EJNMMI Research|December 4, 2017
Pretargeting of internalizing trastuzumab and cetuximab with a 18F-tetrazine tracer in xenograft modelsOuti Keinänen, Kimberly Fung, Jacob Pourat, et al.ACS Chemical Neuroscience|November 10, 2021
Novel Thienopyrimidine-Based PET Tracers for P2Y12 Receptor Imaging in the BrainBerend van der Wildt, Bieneke Janssen, Aleksandra Pekošak, et al.Nuclear Medicine and Biology|September 7, 2021
Comparison of analytical methods for antibody conjugates with application in nuclear imaging - Report from the trenchesIrene V J Feiner, Beatrice Longo, Vanessa Gómez-Vallejo, et al.Plos One|January 7, 2017
Performance of 89Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell LymphomaYvonne W S Jauw, Josée M Zijlstra, Daphne de Jong, et al.Molecular Cancer Therapeutics|January 8, 2017
Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click ChemistryJacob L Houghton, Rosemery Membreno, Dalya Abdel-Atti, et al.Molecular Pharmaceutics|May 16, 2023
Visualizing Galectin-3 Binding Protein Expression with ImmunoPETOuti Keinänen, Samantha M Sarrett, Samantha Delaney, et al.Bioconjugate Chemistry|October 20, 2015
(18)F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels-Alder Click ChemistryJan-Philip Meyer, Jacob L Houghton, Paul Kozlowski, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2016
Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node MetastasisSai Kiran Sharma, Kuntal K Sevak, Sebastien Monette, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 22, 2013
Phase 0 microdosing PET study using the human mini antibody F16SIP in head and neck cancer patientsDerrek A Heuveling, Remco de Bree, Danielle J Vugts, et al.Pageof 22